Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and the healthcare supply chain.
Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; and the healthcare supply chain.
Issues related to the distribution and sale of pharmaceutical and medical products and services; drug shortages; Food as Medicine; and the healthcare supply chain.
Duration: September 1, 2016
to
present
General Issues: Health Issues , Pharmacy , Disaster Planning/Emergencies , Budget/Appropriations , Miscellaneous Tariff Bills , Taxation/Internal Revenue Code , Alcohol & Drug Abuse , Medicare/Medicaid
Spending: about $1,022,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2016: U.S. Senate, House of Representatives
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Jack Fields Former Member of Congress
Lisa Rulli Former Staffer, Committee on Merchant Marine & Fisheries; Committee on Natural Resources
Former Staffer, Committee on Merchant Marine & Fisheries; Committee on
Natural Resources
Former Staffer, Committee on Merchant Marine & Fisheries; Committee on Natural Resources
Former staffer, Committee on Merchant Marine & Fisheries; Committee on Natural Resources
Former staffer, Committee on Merchant Marine & Fisheries, Committee on Natural Resources
Lindsay Flynn n/a
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, TWENTY-FIRST CENTURY GROUP, INC. lobbied for Cardinal Health, Inc. , earning $24,000. The report was filed on April 23.
Original Filing: 301576768.xml
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and the healthcare supply chain.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; and the healthcare supply chain.
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services; drug shortages; Food as Medicine; and the healthcare supply chain.
Agencies Lobbied
U.S. Senate
4th Quarter, 2023
In Q4, TWENTY-FIRST CENTURY GROUP, INC. lobbied for Cardinal Health, Inc. , earning $24,000. The report was filed on Jan. 17.
Original Filing: 301526924.xml
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; COVID-19 pandemic response; and the healthcare supply chain.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Emergencies
3rd Quarter, 2023
In Q3, TWENTY-FIRST CENTURY GROUP, INC. lobbied for Cardinal Health, Inc. , earning $24,000. The report was filed on Oct. 17, 2023.
Original Filing: 301502760.xml
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; COVID-19 pandemic response; and the healthcare supply chain.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Emergencies
2nd Quarter, 2023
In Q2, TWENTY-FIRST CENTURY GROUP, INC. lobbied for Cardinal Health, Inc. , earning $24,000. The report was filed on July 19, 2023.
Original Filing: 301482906.xml
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; COVID-19 pandemic response; and the healthcare supply chain.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Emergencies
1st Quarter, 2023
In Q1, TWENTY-FIRST CENTURY GROUP, INC. lobbied for Cardinal Health, Inc. , earning $24,000. The report was filed on April 18, 2023.
Original Filing: 301455405.xml
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; COVID-19 pandemic response; and the healthcare supply chain.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Emergencies
4th Quarter, 2022
In Q4, TWENTY-FIRST CENTURY GROUP, INC. lobbied for Cardinal Health, Inc. , earning $24,000. The report was filed on Jan. 19, 2023.
Original Filing: 301434373.xml
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; COVID-19 pandemic response; and the healthcare supply chain.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Emergencies/Appropriations
3rd Quarter, 2022
In Q3, TWENTY-FIRST CENTURY GROUP, INC. lobbied for Cardinal Health, Inc. , earning $24,000. The report was filed on Oct. 20, 2022.
Original Filing: 301417920.xml
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; COVID-19 pandemic response; and the healthcare supply chain.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Emergencies/Appropriations
2nd Quarter, 2022
In Q2, TWENTY-FIRST CENTURY GROUP, INC. lobbied for Cardinal Health, Inc. , earning $24,000. The report was filed on July 18, 2022.
Original Filing: 301382849.xml
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; COVID-19 pandemic response; and the healthcare supply chain.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Emergencies/Appropriations
1st Quarter, 2022
In Q1, TWENTY-FIRST CENTURY GROUP, INC. lobbied for Cardinal Health, Inc. , earning $40,000. The report was filed on April 19, 2022.
Original Filing: 301361132.xml
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; COVID-19 pandemic response; and the healthcare supply chain.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Emergencies
4th Quarter, 2021
In Q4, TWENTY-FIRST CENTURY GROUP, INC. lobbied for Cardinal Health, Inc. , earning $40,000. The report was filed on Jan. 19, 2022.
Original Filing: 301327717.xml
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; COVID-19 pandemic response; and the healthcare supply chain.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Emergencies
3rd Quarter, 2021
In Q3, TWENTY-FIRST CENTURY GROUP, INC. lobbied for Cardinal Health, Inc. , earning $40,000. The report was filed on Oct. 19, 2021.
Original Filing: 301303464.xml
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; COVID-19pandemic response; and the healthcare supply chain.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Emergencies
2nd Quarter, 2021
In Q2, TWENTY-FIRST CENTURY GROUP, INC. lobbied for Cardinal Health, Inc. , earning $40,000. The report was filed on July 19, 2021.
Original Filing: 301282737.xml
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; COVID-19pandemic response; and the healthcare supply chain.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Emergencies
1st Quarter, 2021
In Q1, TWENTY-FIRST CENTURY GROUP, INC. lobbied for Cardinal Health, Inc. , earning $40,000. The report was filed on April 19, 2021.
Original Filing: 301259243.xml
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; COVID-19pandemic response; and the healthcare supply chain.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Emergencies
4th Quarter, 2020
In Q4, TWENTY-FIRST CENTURY GROUP, INC. lobbied for Cardinal Health, Inc. , earning $40,000. The report was filed on Jan. 20, 2021.
Original Filing: 301240300.xml
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; COVID-19 pandemic response; and the healthcare supply chain.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Emergencies
3rd Quarter, 2020
In Q3, TWENTY-FIRST CENTURY GROUP, INC. lobbied for Cardinal Health, Inc. , earning $40,000. The report was filed on Oct. 20, 2020.
Original Filing: 301222606.xml
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; COVID-19 pandemic response;and the healthcare supply chain.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Emergencies
2nd Quarter, 2020
In Q2, TWENTY-FIRST CENTURY GROUP, INC. lobbied for Cardinal Health, Inc. , earning $40,000. The report was filed on July 16, 2020.
Original Filing: 301189262.xml
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; COVID-19 pandemic response;and the healthcare supply chain.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Emergencies
1st Quarter, 2020
In Q1, TWENTY-FIRST CENTURY GROUP, INC. lobbied for Cardinal Health, Inc. , earning $40,000. The report was filed on April 17, 2020.
Original Filing: 301170187.xml
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; COVID-19 pandemic response;and the healthcare supply chain.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Emergencies
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Exclusion of health care related products in section 301 tariffs.
Agencies Lobbied
U.S. Senate
Type of Issue
Miscellaneous Tariff Bills
4th Quarter, 2019
In Q4, TWENTY-FIRST CENTURY GROUP, INC. lobbied for Cardinal Health, Inc. , earning $40,000. The report was filed on Jan. 21, 2020.
Original Filing: 301126536.xml
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services, including medical and public health preparedness.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services, including medical and public health preparedness, molybdenum-99 (Moly-99), and telepharmacy.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services, including HR 2207, medical device tax repeal.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Exclusion of health care related products in section 301 tariffs.
Agencies Lobbied
U.S. Senate
Type of Issue
Miscellaneous Tariff Bills
3rd Quarter, 2019
In Q3, TWENTY-FIRST CENTURY GROUP, INC. lobbied for Cardinal Health, Inc. , earning $40,000. The report was filed on Oct. 21, 2019.
Original Filing: 301075244.xml
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services, including medical and public health preparedness.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services, including medical and public health preparedness and telepharmacy.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services, including HR 2207, medical device tax repeal.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Exclusion of health care related products in section 301 tariffs.
Agencies Lobbied
U.S. Senate
Type of Issue
Miscellaneous Tariff Bills
2nd Quarter, 2019
In Q2, TWENTY-FIRST CENTURY GROUP, INC. lobbied for Cardinal Health, Inc. , earning $40,000. The report was filed on July 19, 2019.
Original Filing: 301051530.xml
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services, including medical and public health preparedness.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services, including medical and public health preparedness and telepharmacy.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services, including HR 2207, medical device tax repeal.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Exclusion of health care related products in proposed section 301 tariffs. Educate on potential impact of tariffs on goods from Mexico.
Agencies Lobbied
U.S. Senate
Type of Issue
Miscellaneous Tariff Bills
1st Quarter, 2019
In Q1, TWENTY-FIRST CENTURY GROUP, INC. lobbied for Cardinal Health, Inc. , earning $40,000. The report was filed on April 22, 2019.
Original Filing: 301036045.xml
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services, including medical and public health preparedness and telepharmacy.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services, including medical device tax.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2018
In Q4, TWENTY-FIRST CENTURY GROUP, INC. lobbied for Cardinal Health, Inc. , earning $40,000. The report was filed on Jan. 22, 2019.
Original Filing: 301014467.xml
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services.
Agencies Lobbied
U.S. Senate
Type of Issue
Alcohol & Drug Abuse/Internal Revenue Code
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services, including medical and public health preparedness response.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Appropriations
3rd Quarter, 2018
In Q3, TWENTY-FIRST CENTURY GROUP, INC. lobbied for Cardinal Health, Inc. , earning $40,000. The report was filed on Oct. 19, 2018.
Original Filing: 300990692.xml
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services.
Agencies Lobbied
U.S. Senate
Type of Issue
Alcohol & Drug Abuse/Internal Revenue Code/Medicaid
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services, including medical and public health preparedness response.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Appropriations
2nd Quarter, 2018
In Q2, TWENTY-FIRST CENTURY GROUP, INC. lobbied for Cardinal Health, Inc. , earning $40,000. The report was filed on July 20, 2018.
Original Filing: 300976962.xml
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services.
Agencies Lobbied
U.S. Senate
Type of Issue
Alcohol & Drug Abuse/Internal Revenue Code/Medicaid
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services, including medical and public health preparedness response.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Appropriations
1st Quarter, 2018
In Q1, TWENTY-FIRST CENTURY GROUP, INC. lobbied for Cardinal Health, Inc. , earning $30,000. The report was filed on April 20, 2018.
Original Filing: 300952662.xml
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services.
Agencies Lobbied
U.S. Senate
Type of Issue
Alcohol & Drug Abuse/Medicaid
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services, including medical and public health preparedness response.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Appropriations
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services; medical device tax.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2017
In Q4, TWENTY-FIRST CENTURY GROUP, INC. lobbied for Cardinal Health, Inc. , earning $30,000. The report was filed on Jan. 22, 2018.
Original Filing: 300934797.xml
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services.
Agencies Lobbied
U.S. Senate
Type of Issue
Alcohol & Drug Abuse/Medicaid
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services; HR 1628 American Health Care Act; HR 2810, National Defense Authorization Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services; HR 2810, National Defense Authorization Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services; medical device tax; and tax reform.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2017
In Q3, TWENTY-FIRST CENTURY GROUP, INC. lobbied for Cardinal Health, Inc. , earning $30,000. The report was filed on Oct. 20, 2017.
Original Filing: 300914803.xml
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services.
Agencies Lobbied
U.S. Senate
Type of Issue
Alcohol & Drug Abuse/Medicaid
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services; HR 1628 American Health Care Act; HR 2810, National Defense Authorization Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services; HR 2810, National Defense Authorization Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services; LIFO; medical device tax; and tax reform.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2017
In Q2, TWENTY-FIRST CENTURY GROUP, INC. lobbied for Cardinal Health, Inc. , earning $30,000. The report was filed on July 20, 2017.
Original Filing: 300896634.xml
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services.
Agencies Lobbied
U.S. Senate
Type of Issue
Alcohol & Drug Abuse/Medicaid
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services; HR 1628 American Health Care Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services; LIFO; medical device tax; and tax reform.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2017
In Q1, TWENTY-FIRST CENTURY GROUP, INC. lobbied for Cardinal Health, Inc. , earning $30,000. The report was filed on April 20, 2017.
Original Filing: 300874326.xml
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services.
Agencies Lobbied
U.S. Senate
Type of Issue
Alcohol & Drug Abuse/Medicaid
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services; HR 1628 American Health Care Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services; LIFO and tax reform.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2016
In Q4, TWENTY-FIRST CENTURY GROUP, INC. lobbied for Cardinal Health, Inc. , earning $30,000. The report was filed on Jan. 23, 2017.
Original Filing: 300855879.xml
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services.
Agencies Lobbied
U.S. Senate
Type of Issue
Alcohol & Drug Abuse/Internal Revenue Code/Medicaid
3rd Quarter, 2016
In Q3, TWENTY-FIRST CENTURY GROUP, INC. lobbied for Cardinal Health, Inc. , earning $10,000. The report was filed on Oct. 19, 2016.
Original Filing: 300832943.xml
Lobbying Issues
Issues related to the distribution and sale of pharmaceutical and medical products and services.
Agencies Lobbied
U.S. Senate
Type of Issue
Alcohol & Drug Abuse/Internal Revenue Code/Medicaid
3rd Quarter, 2016
Twenty-First Century Group, Inc. filed a lobbying registration on Sept. 28, 2016 to represent Cardinal Health, Inc., effective Sept. 1, 2016.
Original Filing: 300824679.xml
Issue(s) they said they’d lobby about: Healthcare, tax and labor issues related to the distribution and sale of pharmaceutical and medical products and services. .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...